American Health Staffing Group

AHSG does not market itself as an investment firm — it is a healthcare staffing and technology operating company. Strategic decisions are led by CEO Kelly Rakowski, with Chief Growth Officer Trevor Strauss driving brand and market expansion. The firm has not disclosed any institutional investment activity, private equity backing, or an investment committee structure. Decision-making authority appears to rest with the C-suite, not a separate investment team.

AHSG operates as a holding umbrella for six distinct brands: AHS NurseStat, AHS MedStat, AHS RenalStat, AHS Staffing, PediaStaff, and its managed service provider arm, AHSA. Each brand targets a specific staffing vertical — travel nursing, allied health, dialysis, general travel/local placements, pediatric therapy, and MSP services respectively. The Trio Workforce Solutions VMS platform sits underneath, powering the technology layer across all brands.

There is no evidence AHSG makes fund commitments or direct investments in external companies. The firm's capital appears entirely deployed into operating its staffing agencies and building its Trio VMS technology. If AHSG has an investment arm or a portfolio of outside company stakes, it has not disclosed that information publicly.

Trio is AHSG's proprietary vendor-neutral workforce management platform, designed to help health systems track and optimize their temporary staffing spend across multiple agencies. Unlike standalone VMS companies, Trio is owned by a staffing operator, which means the technology is built and refined using data flowing directly from AHSG's own agency placements. The firm positions Trio as a replacement for traditional MSPs.

No. AHSG is an operating company in the healthcare staffing sector. It has not disclosed any connection to family office capital, wealth management services, or single-family office governance. The listed principals are staffing-industry operators, not investment managers.